PSMD1 and COVID-19: Here, we describe the development of a COVID-19 Multiplex Assay to simultaneously quantify antibodies directed against three SARS-CoV-2 antigens, NP, RBD, and S1, as indicators of previous SARS-CoV-2 exposure.